Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
Personalis announced that its EDTA and cfDNA blood collection kits have obtained Class A CE-IVD marking under the EU’s In Vitro Diagnostic Regulation. This regulatory clearance allows clinical trial sites in the European Union and Great Britain to use the kits for interventional studies, ensuring sample integrity for genomic analysis.
Key figures
- Regulatory mark
- Class A CE-IVD
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.